Therapeutic Neovascularization for Refractory Angina-Are We Any Closer?
作者信息
Alkhunaizi Fatimah A, Burkhoff Daniel
机构信息
Division of Cardiology, Columbia University Medical Center, New York, New York.
Cardiovascular Research Foundation, New York, New York.
出版信息
J Soc Cardiovasc Angiogr Interv. 2023 Jan-Feb;2(1). doi: 10.1016/j.jscai.2022.100557. Epub 2022 Nov 28.
Abstract
摘要
相似文献
1
Therapeutic Neovascularization for Refractory Angina-Are We Any Closer?用于难治性心绞痛的治疗性血管新生——我们更接近目标了吗？
J Soc Cardiovasc Angiogr Interv. 2023 Jan-Feb;2(1). doi: 10.1016/j.jscai.2022.100557. Epub 2022 Nov 28.
2
Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.不可手术的冠心病和难治性心绞痛的治疗：脊髓刺激器、硬膜外治疗、基因治疗、经心肌激光打孔术和反搏术。
Semin Cardiothorac Vasc Anesth. 2004 Mar;8(1):43-58. doi: 10.1177/108925320400800109.
3
Therapeutic angiogenesis for the management of refractory angina: current concepts.治疗性血管生成治疗难治性心绞痛：当前的概念。
Cardiovasc Ther. 2011 Dec;29(6):e1-e11. doi: 10.1111/j.1755-5922.2010.00153.x. Epub 2010 Apr 9.
4
Refractory Angina: the Current State of Mechanical Therapies.难治性心绞痛：机械治疗的现状。
Curr Cardiol Rep. 2019 Apr 22;21(6):46. doi: 10.1007/s11886-019-1134-8.
5
Refractory angina pectoris: lessons from the past and current perspectives.难治性心绞痛：过去的经验教训和当前的观点。
Curr Pharm Des. 2013;19(9):1658-72.
6
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.增强型体外反搏（EECP）：基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
7
Treatment of refractory angina pectoris.难治性心绞痛的治疗。
Int J Cardiol. 2005 May 11;101(1):1-7. doi: 10.1016/j.ijcard.2004.03.066.
8
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.经心外膜递送 XC001 基因治疗治疗难治性心绞痛冠状动脉疾病（EXACT 试验）：基本原理、设计和临床考虑。
Am Heart J. 2021 Nov;241:38-49. doi: 10.1016/j.ahj.2021.06.013. Epub 2021 Jul 2.
9
Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.骨髓间充质基质细胞自体移植治疗严重稳定型冠心病伴难治性心绞痛患者：最终 3 年随访结果。
Int J Cardiol. 2013 Dec 10;170(2):246-51. doi: 10.1016/j.ijcard.2013.10.079. Epub 2013 Oct 28.
10
A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan.体外心脏冲击波治疗难治性心绞痛的多中心试验：日本高度先进医疗的报告。
Heart Vessels. 2019 Jan;34(1):104-113. doi: 10.1007/s00380-018-1215-4. Epub 2018 Jun 25.
引用本文的文献
1
Black Chokeberry () Juice Supplementation Affects Age-Related Myocardial Remodeling in Rats.黑果腺肋花楸汁补充剂对大鼠年龄相关的心肌重塑有影响。
Life (Basel). 2024 Dec 28;15(1):23. doi: 10.3390/life15010023.
2
2022: The Year in Review.2022年回顾
J Soc Cardiovasc Angiogr Interv. 2023 Mar 15;2(2):100605. doi: 10.1016/j.jscai.2023.100605. eCollection 2023 Mar-Apr.
本文引用的文献
1
Contemporary Management of Refractory Angina.当代难治性心绞痛的管理。
Interv Cardiol Clin. 2022 Jul;11(3):279-292. doi: 10.1016/j.iccl.2022.03.002.
2
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.经心外膜递送 XC001 基因治疗治疗难治性心绞痛冠状动脉疾病（EXACT 试验）：基本原理、设计和临床考虑。
Am Heart J. 2021 Nov;241:38-49. doi: 10.1016/j.ahj.2021.06.013. Epub 2021 Jul 2.
3
Therapeutic Approaches for the No-Option Refractory Angina Patient.无选择难治性心绞痛患者的治疗方法。
Circ Cardiovasc Interv. 2021 Feb;14(2):e009002. doi: 10.1161/CIRCINTERVENTIONS.120.009002. Epub 2021 Feb 5.
4
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞经皮冠状动脉介入治疗的指导原则。
Circulation. 2019 Jul 30;140(5):420-433. doi: 10.1161/CIRCULATIONAHA.119.039797. Epub 2019 Jul 29.
5
Reappraisal of Ischemic Heart Disease.缺血性心脏病再评估。
Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.
6
Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.CD34 阳性细胞移植对心肌梗死后功能再生恢复过程中并发血管生成和心肌生成的剂量依赖性作用。
Circulation. 2006 Mar 14;113(10):1311-25. doi: 10.1161/CIRCULATIONAHA.105.541268.
7
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.一项关于经皮激光心肌血运重建术改善严重冠心病患者心绞痛症状的双盲、随机、安慰剂对照试验。
J Am Coll Cardiol. 2005 Nov 15;46(10):1812-9. doi: 10.1016/j.jacc.2005.06.079. Epub 2005 Oct 19.
8
Angiogenesis: where do we stand now?血管生成：我们目前的进展如何？
Circulation. 2005 Mar 29;111(12):1556-66. doi: 10.1161/01.CIR.0000159345.00591.8F.
9
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.血管内皮生长因子与碱性成纤维细胞生长因子对体内血管生成的协同作用。
Circulation. 1995 Nov 1;92(9 Suppl):II365-71. doi: 10.1161/01.cir.92.9.365.
Zotero 插件